ACT on MASH: A multicountry survey of awareness, understanding, and perceptions of MASLD and MASH, and their relation to cardiometabolic comorbidities, among people with MASLD/MASH or at risk for MASH
Sahar Saeed, PhD1; Husam Albarmawi, PhD2; Edwige-Ludiwyne Balzac, PhD3; Julio Burman4; Nathalie Eklöf, MD5; Takumi Kawaguchi, MD, PhD6; Nobuyoshi Kosaka, PhD7; Jeff McIntyre, MA8; Lauren D. Nephew, MD9; Arash Pakseresht, MD10; Jörn M. Schattenberg, MD11; Cyrielle Caussy, MD, PhD12,13
MATERIALS AVAILABLE
Poster
08:30 - 17:00
CEST
WED-072
POSTER
ACT on MASH: A multicountry online survey of awareness, understanding, and perceptions of MASLD/MASH and cardiometabolic associations among healthcare professionals
Cyrielle Caussy, MD, PhD1,2; Husam Albarmawi, PhD3; Edwige-Ludiwyne Balzac, PhD4; Julio Burman5; Nathalie Eklöf, MD6; Takumi Kawaguchi, MD, PhD7; Nobuyoshi Kosaka, PhD8; Jeff McIntyre, MA9; Lauren D. Nephew, MD10; Arash Pakseresht, MD11; Sahar Saeed, PhD12; Jörn M. Schattenberg, MD13;
MATERIALS AVAILABLE
Poster
Thursday, 28 May 2026
12:45 - 13:45
CEST
Symposium
Rethinking MASH: Time to explore a multisystem treatment approach
Aleksander Krag; Meena B. Bansal; Kirsi Pietiläinen; Pam R. Taub
MATERIALS AVAILABLE
Teaser Video
Summary of the symposium
Summary of the symposium
Summary of the symposium
Friday, 29 May 2026
08:30 - 17:00
CEST
FRI-181
POSTER
Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study
Semaglutide Shows Favourable Safety Across Subgroups and a Positive Hepatic Safety Profile: Findings from ESSENCE Part 1
Philip N. Newsome1,2; Michael Roden3-5; Igor Bakulin6; Burak Demirel7; Christina Egebjerg7; Anja Geerts8;George Boon Bee Goh9; Laura Ladrón de Guevara10; Mette Skalshøi Kjaer7; Tomáš Koller11; Heidi Ranndal7; Jörn M. Schattenberg12-14; Elisabetta Bugianesi15; Mary E. Rinella16
MATERIALS AVAILABLE
Poster
08:30 - 17:00
CEST
POSTER
Semaglutide Provides Liver Health-Related Benefits in Menopausal Women Living with MASH: A Post Hoc Analysis of the ESSENCE Trial Part 1
Manal F. Abdelmalek1; Maria Teresa Arias-Loste2; Burak Demire3; Gema Fruhbeck4; Anja Geerts5; Lise Lotte Gluud6;Laura Ladron de Guevara7; Ewa Janczewska8; Ole Kleist; Jeppesen3; Claudia Oliviera9; Mary E. Rinella10; Giada Sebastiani11; Anca Trifan12; Thea Vestergaard3; Elisabetta Bugianesi13
MATERIALS AVAILABLE
Poster
16:15 - 16:45
CEST
Symposium
FGF21 analogues: From pathways to clinical implications